Clinical Trial Update: Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine [Phase 4]

View source ↗

Summary

This update discusses a Phase 4 study evaluating a booster strategy with a pneumococcal conjugate vaccine in liver transplant recipients to enhance protection a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation
• Pneumonia

Drugs mentioned

• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Transplant | Phase 4 | Status: UNKNOWN